mutations, respectively.11 One of the most attention-grabbing post hoc findings from TRITON2 study was the doable disparity within the success of rucaparib in men with BRCA1??????: ??? ???? ???????? ??????? ???? ????? ?? ????? ????????? ?????? ??????? ??? ????? ?????? ?? ????????.?????? ??????????? ???? ??????? ????? ???? ??? ????? ?????? ??????? ?

???? ?????? ?? ????? ????? ?? ???? ????? ?????? ??????? ???????:???? ????? ?????? ????? ???? ???? ?? ??????? ?????? ????? ?? ???? ??????? ?????.???? ??????? ?? ????? ?????? ????? ?????? ??????? ??????.?? ???? ?????? ?????? ?????? ??????? ???? ????? ????? ?? ????? ???? ???? ?????.???????: ?????? ????? ????? ??????? ?????? ??????? ?????? ?????? ?????

????? ????? ?? ???? ?????? ???? ????? ?? ???? ?????? ??????? ???? ?? ????? ??? ?? ??????????? ????? ????? ?????? ?? ????? ??????, ????? ????? ?? ????? ??? ?? ????????????????? ????? ??????? ???????? ??????? ????? ????????????? ????? ????? ??? ????? ????? ??????. ?????? ????? ??????? ???? ?????? ??? ?? ?????? ??? ??????? ???? ?????? ?? ???? ??? ????

???? ???? ?? ??? ???????? ?? ??????? ???????? ????? ??? ???????? ?????? ??? ??? ?????? … ?????? ????? ????? ??????? ?? ???????? ????? ??????? ???????? ?????? ??????? ????? ?????? ????? ??? ??? ?????? ???? ???????? ?? ???:????? ??? ???????? ?? ??? ?????? ??? ????? ???? ?????? ???? ???????? ??????? ??????? ??? ??????? ?????????? ???? ?? ???? ?????

????? ??? ??? ????? ??????? ??? ????? ????? ?? ????? ??????? ?? ???? ?????.????? ????? ?????? ??? ????? ?????????? ??????? ?????? ????? ????????? ?????? ??????? ?????????? ?????????.????? ???????? ?????? ??????? ?????????.. ????? ??????? ??????? (????)????? ?????? ???????: ?????? ?? ????? ??????? ??????? ?????? ????????? ???????.?????? ???? ?? ????